The critical gap in inflammaging research is whether JNK-AP-1 signaling causally locks in senescence through stable chromatin remodeling. Current evidence shows mitochondrial ROS activate JNK, which induces AP-1-dependent genes like TREM1, but lacks direct proof of AP-1 binding at SASP enhancers during the acute-to-chronic transition [https://doi.org/10.1101/gad.331272.119, https://pmc.ncbi.nlm.nih.gov/articles/PMC12033962/]. This hypothesis proposes that sustained JNK activation, driven by chronic minority mitochondrial outer membrane permeabilization (miMOMP), triggers AP-1-mediated epigenetic locking at specific SASP loci, converting transient stress responses into persistent senescence. The lock-in is determined by kinetics: acute miMOMP resolves JNK signaling, while prolonged miMOMP leads to AP-1 chromatin occupancy that remodels enhancers via histone modifications like H3K27ac [https://doi.org/10.1101/gr.240093.118]. Tissue specificity arises from pre-existing epigenetic landscapes—aging-driven H3K4me3 marks prime certain SASP genes for rapid AP-1 binding, explaining why acute injury induces spatially restricted senescence in some tissues but not others [https://doi.org/10.1038/s41598-021-95344-5, https://doi.org/10.1111/acel.13201].

Core Mechanistic Insight

• Threshold Problem: Acute miMOMP activates JNK transiently, allowing resolution via negative feedback (e.g., phosphatases), but chronic miMOMP exceeds a threshold where JNK-AP-1 signaling becomes self-sustaining. This aligns with the "JNK-AP-1 Threshold Problem" from recent discussions—why aren't we dead yet? Because acute activation is buffered, but aging increases miMOMP frequency, pushing systems past thresholds.
• Signal-to-Noise Paradox: The "JNK-AP-1 Paradox" highlights failing signal-to-noise ratios; hypothesize that aging increases basal JNK activity, reducing the dynamic range for acute responses. AP-1 binding at SASP enhancers may become stochastic, leading to heterocellular senescence patterns.
• Link to Proteostasis Collapse: From the thread on senescence-proteostasis bridge, propose that sustained JNK-AP-1 upregulates SASP factors that inhibit autophagy, creating a feedback loop where proteotoxic stress further amplifies miMOMP and JNK activation [https://pmc.ncbi.nlm.nih.gov/articles/PMC3227503/].

Testable Predictions

1. Genetic Models: Use conditional JNK or AP-1 knockout mice with inducible miMOMP (e.g., via mitochondrial toxins). Time-resolved phosphoproteomics should show sustained JNK activation correlating with AP-1 target gene expression only in wild-type, not knockouts.
2. ChIP-seq and Epigenomics: Perform AP-1 ChIP-seq and H3K27ac profiling at SASP enhancers in young vs. aged tissues after acute injury. Predict stable AP-1 occupancy and enhancer remodeling in aged tissues, but transient binding in young tissues.
3. Tissue Specificity: Compare fibroblasts (high senescence propensity) with neurons (low propensity) under miMOMP induction. Expect pre-existing H3K4me3 marks at SASP genes in fibroblasts facilitate faster AP-1 binding and lock-in.
4. Falsifiability: If AP-1 binding does not correlate with chromatin changes, or if genetic ablation of AP-1 fails to prevent senescence in chronic miMOMP models, the hypothesis is disproven.

This framework moves beyond correlation, proposing a causal cascade from miMOMP kinetics to epigenetic memory, with implications for timing interventions against inflammaging.